Is there a place for cellular therapy in depression?

Although efforts have been made to improve the pharmacological treatment of depression, approximately one-third of patients with depression do not respond to conventional therapy using antidepressants. Other potential non-pharmacological therapies have been studied in the last years, including the u...

Full description

Saved in:
Bibliographic Details
Published in:World journal of psychiatry 2021-09, Vol.11 (9), p.553-567
Main Authors: do Prado-Lima, Pedro Antônio Schmidt, Costa-Ferro, Zaquer Suzana Munhoz, Souza, Bruno Solano de Freitas, da Cruz, Ivana Beatrice Manica, Lab, Biogenomics
Format: Article
Language:English
Subjects:
Minireviews
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Although efforts have been made to improve the pharmacological treatment of depression, approximately one-third of patients with depression do not respond to conventional therapy using antidepressants. Other potential non-pharmacological therapies have been studied in the last years, including the use of mesenchymal stem cell therapies to treat depression. These therapies are reviewed here since it is clinically relevant to develop innovative therapeutics to treat psychiatric patients. Experimental data corroborate that mesenchymal stem cell therapy could be considered a potential treatment for depression based on its anti-inflammatory and neurotrophic properties. However, some clinical trials involving treatment of depression with stem cells are in progress, but with no published results. These studies and other future clinical investigations will be crucial to define how much mesenchymal stem cells can effectively be used in psychiatric clinics as a strategy for supporting depression treatment.
ISSN:2220-3206
2220-3206
DOI:10.5498/wjp.v11.i9.553